Goldman Lowers PT on Realty Income (O)
Get Alerts O Hot Sheet
Price: $61.53 --0%
Rating Summary:
17 Buy, 22 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 24
Rating Summary:
17 Buy, 22 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 24
Join SI Premium – FREE
Goldman Sachs today maintained a Sell rating on Realty Income (NYSE: O) with a modified price target of $44.00 (from $51.00). Like other REITs, Realty income has traded lower since Fed Chairman Ben Bernanke's speech on May 21st. It is also among the worst performers in the sector, declining 24% vs 12% for the REIT index.
Commenting, analyst Andrew Rosivach said, "We shift our Realty Income price target to $44 to $51, which represents a 10% total return, and is one of the lowest in our coverage universe. O trades at 18.6X 2013E AFFO, which is a 9% discount to the sector average. However, compared to traditional REITs with quasi-net lease characteristics (such as strip and healthcare REITs), O trades at a premium. In addition, on 2018E AFFO, O trades at a 5% premium to the sector."
For an analyst ratings summary and ratings history on Realty Income (NYSE: O) click here. For more ratings news on Realty Income click here.
Shares of Realty Income closed at $41.85 yesterday.
Commenting, analyst Andrew Rosivach said, "We shift our Realty Income price target to $44 to $51, which represents a 10% total return, and is one of the lowest in our coverage universe. O trades at 18.6X 2013E AFFO, which is a 9% discount to the sector average. However, compared to traditional REITs with quasi-net lease characteristics (such as strip and healthcare REITs), O trades at a premium. In addition, on 2018E AFFO, O trades at a 5% premium to the sector."
For an analyst ratings summary and ratings history on Realty Income (NYSE: O) click here. For more ratings news on Realty Income click here.
Shares of Realty Income closed at $41.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Backblaze Inc (BLZE) PT Raised to $14 at Needham
- Cantor Fitzgerald Starts Silence Therapeutics (SLN) at Overweight
- Evercore ISI Starts Procept BioRobotics Corp (PRCT) at Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Ben S. BernankeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share